Dr. Audrey S. Wang, MD

Dr. Wang practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Wang's NPI, 1669609681, was assigned on June 17, 2009. Dr. Wang graduated from Harvard Medical School in 2009. Dr. Wang holds California license A113188.

Dr. Wang's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Wang's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Dr. Wang to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices. Vendor and product names are available with a free account.

Dermatology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Wang is board certified in dermatology by the American Board of Dermatology. Dr. Wang is licensed in California.

Dmand AI lists benign or precancerous skin growths, contact dermatitis, itchy rashes, scalp rash, skin cyst and skin discoloration among the conditions Dr. Wang treats.

CMS data shows 231 Medicare services from Dr. Wang across 6 procedure codes in 2024, for 59 Medicare patients. Medicare paid $8,535 for them. Every service was in an office.

CMS counts 59 Medicare patients who saw Dr. Wang in 2024. The largest group is 65 to 74, with 36 patients. 53% of them have high cholesterol, and 51% have high blood pressure. Their average risk score is 0.62, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 54, with 57% women.

In 2024, Dr. Wang wrote 249 Medicare Part D claims for 101 patients. 86% of them were for generic drugs. CMS names the drug for 131 of them, across 6 drugs with 11 or more claims each, at $4,362 in total drug cost. In 2023, CMS named 215 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth. CMS counts 173 procedures of removal of skin lesions by Dr. Wang, more than 78% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Dr. Wang, published from 2011 to 2021. 2015 was the busiest year, with 3. The most frequent topics are Cell Proliferation, Cellular Senescence and Lamin Type A. Dr. Wang has published most often in JAMA Dermatol. Dr. Wang's most frequent co-authors are Daniel B. Eisen, MD, Jared Jagdeo, MD and Andrew Charles Krakowski, MD.

Dmand AI links Dr. Wang to 1 clinical trial. Conditions studied include Acneiform Eruptions and Acne Vulgaris.

CMS Open Payments shows 69 general payments to Dr. Wang from 17 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $436.

Dr. Wang graduated from Harvard Medical School in 2009.

Dr. Wang is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.